Klineo, a Paris, France-based digital well being startup, raised €2m in funding.
The spherical was by BPI France with participation from enterprise angels.
The corporate intends to make use of the funds to proceed to increase operations, its growth efforts to increase the answer to various kinds of most cancers, and its enterprise attain throughout Europe and US.
Led by CEO Thomas Peyresblanques, and CTO Nicolas Drizard, Klineo supplies an AI powered platform that connects docs and sufferers of most cancers medical trials. In 2022, the corporate arrange a pilot undertaking on the Gustave Roussy Institute and launched a nationwide platform in triple destructive breast most cancers in collaboration with the Collectif Triplettes Roses. In 2023, Klineo prolonged its platform to new cancers (breast, pores and skin, lymphoma, and many others.) and goals to cowl all cancers by the top of 2024.
Klineo additionally advantages from the assist of varied stakeholders such because the BPI, the Pfizer Healthcare Hub , Wilco, Onconumérique, PariSanté Campus and Unicancer.
FinSMEs
29/04/2024
